EarningsQ4 2022 Earnings Report

ANI Pharmaceuticals (BSFA) Q4 2022 Earnings Report

0 Followers

DE:BSFA Q4 2022 EPS Results

Actual EPS€0.68

Consensus EPS€0.60

Beat/MissBeat by +€0.08

One Year Ago EPS€0.48

Actual Revenue€84.37M

Expected Revenue€77.03M

Beat/MissBeat by +€7.34M

YoY Revenue Growth+54.66%

QuarterQ4 2022

Date03/09/2023

TimeBefore Open

Conference CallThursday, March 9, 2023

DE:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

DE:BSFA Q4 2022 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.95 / -	1.826	―
Aug 07, 2026	2026 (Q2)	1.83 / 1.98	1.612	22.78% (+0.37)
May 08, 2026	2026 (Q1)	1.16 / 1.84	1.522	20.59% (+0.31)
Mar 03, 2026	2025 (Q4)	1.78 / 2.09	1.459	42.94% (+0.63)
Nov 10, 2025	2025 (Q3)	1.58 / 1.83	1.2	52.24% (+0.63)
Aug 08, 2025	2025 (Q2)	1.26 / 1.61	0.913	76.47% (+0.70)
May 09, 2025	2025 (Q1)	1.24 / 1.52	1.083	40.50% (+0.44)
Feb 28, 2025	2024 (Q4)	1.28 / 1.46	0.895	63.00% (+0.56)
Nov 08, 2024	2024 (Q3)	0.97 / 1.20	1.137	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.85 / 0.91	1.146	-20.31% (-0.23)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed